Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
1.300
+0.160 (14.04%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Adagio Medical Holdings Revenue
In the year 2024, Adagio Medical Holdings had annual revenue of $602.00K with 100.67% growth. Adagio Medical Holdings had revenue of $137.00K in the quarter ending December 31, 2024, with 75.64% growth.
Revenue (ttm)
$602.00K
Revenue Growth
+100.67%
P/S Ratio
14.44
Revenue / Employee
$7,525
Employees
80
Market Cap
20.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 602.00K | 302.00K | 100.67% |
Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
Dec 31, 2022 | 189.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionADGM News
- 10 days ago - Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System - Business Wire
- 26 days ago - Adagio Medical Appoints Deborah Kaster as Chief Business Officer - Business Wire
- 27 days ago - Adagio Medical Reports Fourth Quarter and Full Year 2024 Results - Business Wire
- 5 weeks ago - Adagio Medical Provides Clinical and Business Updates - Business Wire
- 2 months ago - Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation - Business Wire
- 2 months ago - Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire
- 4 months ago - Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director - Business Wire
- 5 months ago - Adagio Medical Reports Third Quarter 2024 Results - Business Wire